Associated Banc Corp Has $6.61 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Associated Banc Corp cut its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 72,718 shares of the company's stock after selling 3,626 shares during the quarter. Associated Banc Corp's holdings in Colgate-Palmolive were worth $6,611,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Diamond Hill Capital Management Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at about $348,718,000. FMR LLC boosted its holdings in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after acquiring an additional 2,674,807 shares during the last quarter. AMF Tjanstepension AB boosted its holdings in Colgate-Palmolive by 1,088.8% in the fourth quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock valued at $233,584,000 after acquiring an additional 2,353,268 shares during the last quarter. Barclays PLC boosted its holdings in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. Finally, State Street Corp boosted its holdings in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CL. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. Morgan Stanley reduced their target price on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Friday, March 14th. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an "overweight" rating in a report on Friday, March 14th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and a consensus target price of $101.72.

Colgate-Palmolive Stock Up 1.1 %

Colgate-Palmolive stock traded up $0.95 during midday trading on Wednesday, reaching $90.44. The stock had a trading volume of 8,242,135 shares, compared to its average volume of 4,191,857. The firm's fifty day simple moving average is $89.13 and its 200-day simple moving average is $94.44. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The stock has a market capitalization of $73.39 billion, a P/E ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm posted $0.87 EPS. As a group, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.